Home›Obesity Obesity 肥胖 COND-obesity 4interventions reviewed Atop tier 1counter-evidence A Moderate evidence 2 Tirzepatide Tirzepatide (Mounjaro / Zepbound / 穆桂諾) Published with Warning 🚨 高市場風險 → Semaglutide Semaglutide (Ozempic / Wegovy / Rybelsus / 胰妥讚) Published with Warning 🚨 高市場風險 → C Weak 1 Retatrutide 三重激動劑 Retatrutide Published with Warning → D Counter-evidence 1 Bitter Melon Peptide (mcIRBP-19 / MAP30) 苦瓜胜肽（山苦瓜胜肽 / mcIRBP-19） Insufficient Evidence ⚠️ 中度市場風險 → 繁體中文版 →